PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 187 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 5.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $0 | -100.0% | 19 | -100.0% | 0.00% | -100.0% |
Q1 2020 | $3,647,000 | -81.3% | 511,523 | -37.3% | 0.00% | -50.0% |
Q4 2019 | $19,472,000 | -1.3% | 815,437 | +10.8% | 0.00% | 0.0% |
Q3 2019 | $19,732,000 | +39.4% | 735,727 | +41.0% | 0.00% | 0.0% |
Q2 2019 | $14,152,000 | -59.5% | 521,630 | -48.2% | 0.00% | -50.0% |
Q1 2019 | $34,930,000 | +77.6% | 1,006,620 | -0.1% | 0.00% | +33.3% |
Q4 2018 | $19,667,000 | -54.5% | 1,007,572 | -38.0% | 0.00% | -40.0% |
Q3 2018 | $43,260,000 | -42.8% | 1,624,486 | -18.8% | 0.01% | -44.4% |
Q2 2018 | $75,594,000 | +15.6% | 2,001,417 | -0.1% | 0.01% | +12.5% |
Q1 2018 | $65,414,000 | -68.3% | 2,002,885 | -52.8% | 0.01% | -66.7% |
Q4 2017 | $206,659,000 | -33.6% | 4,245,246 | -26.3% | 0.02% | -36.8% |
Q3 2017 | $311,238,000 | +46.2% | 5,760,456 | +52.0% | 0.04% | +46.2% |
Q2 2017 | $212,816,000 | +39.2% | 3,788,783 | -2.9% | 0.03% | +36.8% |
Q1 2017 | $152,919,000 | +84.4% | 3,902,000 | +5.6% | 0.02% | +72.7% |
Q4 2016 | $82,944,000 | -4.6% | 3,696,249 | -3.5% | 0.01% | -8.3% |
Q3 2016 | $86,975,000 | -41.7% | 3,829,815 | -39.4% | 0.01% | -40.0% |
Q2 2016 | $149,198,000 | +14.9% | 6,321,971 | -0.6% | 0.02% | +11.1% |
Q1 2016 | $129,803,000 | -63.6% | 6,362,886 | -8.2% | 0.02% | -62.5% |
Q4 2015 | $356,512,000 | +31.4% | 6,929,286 | +8.9% | 0.05% | +23.1% |
Q3 2015 | $271,260,000 | -4.4% | 6,364,630 | +2.2% | 0.04% | +8.3% |
Q2 2015 | $283,796,000 | +20.8% | 6,230,430 | +0.6% | 0.04% | +20.0% |
Q1 2015 | $235,027,000 | +43.8% | 6,191,430 | +7.3% | 0.03% | +42.9% |
Q4 2014 | $163,387,000 | +39.3% | 5,769,330 | +24.3% | 0.02% | +31.2% |
Q3 2014 | $117,297,000 | -6.3% | 4,639,920 | +8.2% | 0.02% | -5.9% |
Q2 2014 | $125,181,000 | +43.0% | 4,289,950 | +26.9% | 0.02% | +41.7% |
Q1 2014 | $87,565,000 | +93.7% | 3,380,900 | +92.5% | 0.01% | +100.0% |
Q4 2013 | $45,217,000 | +71.2% | 1,756,000 | +77.8% | 0.01% | +50.0% |
Q3 2013 | $26,416,000 | +66.8% | 987,500 | +53.2% | 0.00% | +33.3% |
Q2 2013 | $15,838,000 | – | 644,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 232,952 | $5,498,000 | 5.39% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,673,727 | $86,700,000 | 3.41% |
Redmile Group, LLC | 1,466,537 | $34,610,000 | 3.31% |
SECTORAL ASSET MANAGEMENT INC | 1,229,382 | $29,013,000 | 3.00% |
HARVEY CAPITAL MANAGEMENT INC | 206,530 | $4,874,000 | 2.44% |
Marcus Capital, LLC | 75,150 | $1,774,000 | 1.87% |
Cormorant Asset Management, LP | 396,000 | $9,346,000 | 1.32% |
Rail-Splitter Capital Management, LLC | 221,414 | $5,225,000 | 1.25% |
Temasek Holdings (Private) Ltd | 6,583,568 | $155,372,000 | 1.21% |
EMERALD MUTUAL FUND ADVISERS TRUST | 636,526 | $15,022,000 | 0.84% |